| 6MWD | 6 min walk test distance |
| 6MWT | 6 min walk test |
| AA | ascending aorta |
| CMR | cardiac MRI |
| CT | computed tomography |
| CTEPH | chronic thromboembolic pulmonary hypertension |
| DECT | dual-energy CT |
| DLCO | lung diffusing capacity for carbon monoxide |
| ERA | endothelin receptor antagonist |
| ESC/ERS | European Society of Cardiology/European Respiratory Society |
| FEV1 | forced expiratory volume in 1 s |
| FVC | forced vital capacity |
| ILD | interstitial lung disease |
| LTx | lung transplantation |
| LV | left ventricle |
| MRI | magnetic resonance imaging |
| NYHA | New York Health Organization |
| OSAS | obstructive sleep apnea syndrome |
| PA | pulmonary arteries |
| PAH | pulmonary arterial hypertension |
| PAWP | pulmonary artery wedge pressure |
| PDE-5i | phosphodiesterase-5 inhibitors |
| PFT | pulmonary function testing |
| PH | pulmonary hypertension |
| PVR | pulmonary vascular resistance |
| QOL | quality of life |
| RHC | right heart catheterization |
| RPCT | randomized placebo-controlled trial |
| RVSP | right ventricular systolic pressure |
| SAPH | sarcoidosis-associated pulmonary hypertension |
| TRV | tricuspid regurgitant velocity |
| TTE | transthoracic echocardiography |
| V/Q | ventilation/perfusion |
| WASOG | World Association of Sarcoidosis and other Granulomatosis |
| WHO | World Health Organization |
| WU | Wood’s units |